Ad is loading...
MENU

THAR Stock Tickeron detected bullish Stock Pattern: Head-and-Shoulders Bottom THAR on October 29, 2024, netting in a 28.52% gain over 1 month

A.I.dvisor
at Tickeron.com
Loading...
+28.52% Gain from a Successful pattern Head-and-Shoulders Bottom
THAR - Tharimmune Inc.
Tickeron
Ticker: THAR
Company: Tharimmune
Gain: +28.52%
Confirmed: 10/29/24
Succeeded: 10/29/24
Total length: 39 days
On September 20, 2024, A.I.dvisor detected a Head-and-Shoulders Bottom Pattern (Bullish) for Tharimmune Inc. (THAR, $2.84). On October 29, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $3.23. On October 29, 2024, THAR reached the target price resulting in a +2 for traders who took a long position in the stock.

THAR sees its Stochastic Oscillator ascends from oversold territory

On November 18, 2024, the Stochastic Oscillator for THAR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 38 instances where the indicator left the oversold zone. In of the 38 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 21, 2024. You may want to consider a long position or call options on THAR as a result. In of 56 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for THAR just turned positive on November 21, 2024. Looking at past instances where THAR's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .

THAR moved above its 50-day moving average on November 19, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where THAR advanced for three days, in of 106 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 38 cases where THAR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for THAR moved out of overbought territory on October 31, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 similar instances where the indicator moved out of overbought territory. In of the 6 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The 10-day moving average for THAR crossed bearishly below the 50-day moving average on November 15, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THAR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

THAR broke above its upper Bollinger Band on October 30, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.285) is normal, around the industry mean (13.749). P/E Ratio (0.043) is within average values for comparable stocks, (88.241). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.798). THAR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (221.024).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. THAR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THAR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
THAR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1200 Route 22 East
Phone
+1 908 955-3140
Employees
3
Web
https://www.hillstreambio.com